Patients suffering from neurofibromatosis type 2 (NF2), an autosomal dominant genetic microdeletion on chromosome 22 resulting in a deficiency of the peptide merlin, typically have bilateral vestibular schwannomas at a relatively young age in addition to other intracranial and intraspinal tumors [8]. The gene discussed is NF2; the disease is Vestibular schwannoma.